Detalles de la búsqueda
1.
UK guidelines for the management of soft tissue sarcomas.
Br J Cancer
; 2024 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38734790
2.
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.
Br J Cancer
; 129(9): 1490-1499, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37684354
3.
First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis.
Cancer
; 128(15): 2932-2938, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35561319
4.
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Lancet Oncol
; 20(7): 1023-1034, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31160249
5.
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses.
BMC Cancer
; 19(1): 794, 2019 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31409302
6.
Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database.
Acta Oncol
; 57(8): 1117-1126, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29521151
7.
Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts.
Lancet Oncol
; 18(3): e166-e175, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28271871
8.
The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.
Br J Cancer
; 116(5): 669-678, 2017 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28141799
9.
Pazopanib, a promising option for the treatment of aggressive fibromatosis.
Anticancer Drugs
; 28(4): 421-426, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28099210
10.
Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study.
Acta Oncol
; 56(12): 1769-1775, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28723233
11.
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
Acta Oncol
; 56(7): 1013-1020, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28431480
12.
Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Lancet Oncol
; 17(9): 1261-71, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27498913
13.
Gene expression profiling identifies distinct molecular subgroups of leiomyosarcoma with clinical relevance.
Br J Cancer
; 115(8): 1000-1007, 2016 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27607470
14.
Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072).
Cancer
; 121(17): 2933-41, 2015 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26033286
15.
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumors.
Oncologist
; 20(4): 368-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25795637
16.
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
Pediatr Blood Cancer
; 62(1): 40-4, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25251256
17.
Primary cutaneous and subcutaneous Ewing sarcoma.
Pediatr Blood Cancer
; 62(9): 1555-61, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25894676
18.
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Lancet Oncol
; 15(4): 415-23, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24618336
19.
Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit.
Gastric Cancer
; 17(4): 621-629, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24445485
20.
Prognostic factors for primary gastrointestinal stromal tumours: are they the same in the multidisciplinary treatment era?
Langenbecks Arch Surg
; 399(3): 323-32, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24413830